‘Mylan must be held accountable’: why a generic EpiPen could prevent a cheaper product in the long term
August 29, 2016 at 13:20 PM EDT
The CEO called it an “extraordinary” move. But companies do it all the time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.